Drug Safety Test

The drug development process proceeds in a stepwise manner while evaluating the efficacy and safety information obtained from animals and humans. The nonclinical safety assessment aims to characterize toxicity in terms of target organs, dose dependency, relationship to exposure, and where appropriate, reversibility. This information is used to estimate the safe starting dose and dose range for the first in-human study and identify parameters for monitoring adverse effects in the clinical setting. Nonclinical safety studies conducted before the start of clinical development are usually limited; however, adverse effects that may appear under the conditions of clinical studies must be fully clarified.
FUJIFILM Wako offer various reagents and kits such as toxicity study, pharmacokinetic study, and mutagenicity study.


Hours of Operation: 8:00 - 17:00 (EST)For other hours than the above, please contact us via the inquiry form.